Skip to content

ALPHADENT

Active
Public limited companyfounded 197551 yrs activeMannebeekstraat 33, 8790 Waregem, BelgiumKBO/BCE: BE 0414.789.321
Summary

ALPHADENT has been active since 1975 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €7.5m and a net result of €278,380. Equity is growing by ~2.6% per year across the filed fiscal years. Its solvency ranks better than 95% of 9085 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.3% (very low).

Risk analysisWatch ReportCompare
ALPHADENTActiveChecked score 89/100
Risk analysis ReportCompare

Overview

What they do
Wholesale of pharmaceutical and medical goods
NACE 46460NACE 51460
1 site
How big
€2.4mturnover 2024
Staff
4 FTE
Equity
€7.5m
Profit
€278,380
Net result +201%: other schema
Financially healthy?
89 Excellent Checked score 2024
Bankruptcy chance 12 m
0.3%
Who decides
Parent
ARSEUS LAB · 99.98%
Accounts 6 d early0 of 26 deeds read
Why 89- Higher-failure-rate sector+ Long track record+ Lower-risk legal form+ Annual accounts: healthy financial profileLatest accounts filed on timeShow the evidence

Checked score

Score 2024
89 / 100
Excellent
Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability63▲+46
Solvency100=
Growth35▼-17
Track record100
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €230,000 at 30 days acceptable
Liquidity ample (current ratio 26.99 against 13.07 in 2023; short-term debt: 3.7% and cash: 96.2% of total assets), and 4.3% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 51 years 0 60 y
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
95.7%
Return on assets
3.6%
Age of the figures
21 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Wholesale trade (NACE 46)
about 21% more bankruptcies
← fewer bankruptcies more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 28-12-2024 was due by 28-07-2025 and was filed on 22-07-2025, 6 days ahead of the deadline.
NBB · 9 filings
Deviation from the deadline
2024
6 d early
2023
48 d early
2022
40 d early
2021
39 d early
2020
31 d early
2019
33 d early
2018
32 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 33 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2024 · abbreviated…
  2. Annual accounts filedfiscal year 2023 · full…
  3. Liquidity doublescurrent ratio 26.99

Key points

  • Positive: Result rose in 2024different schema filed ▲ 201% View
  • Positive: Among the best 5% on solvencysector median 44.1% · 9,085 companies 95.7% View
  • Positive: Always filed on timeaccounts within the deadline every year 8 years View
  • Controlled by ARSEUS LAB 99.98% View
  • Positive: 7 profitable years in a rowprofit 2024: €278,380 7 years View
  • Active since 1975founded 27-01-1975 51 years View

By topic

Financials

Fiscal year
2024
Turnover
€2.4m
Profit
€278,380
Solvency
95.7%
Turnover▼ 28.6%
Net result
20232024
Go to Financials

Timeline

Events
12
Since
2017
  1. 22-07-2025Annual accounts filed
  2. 23-01-2025Annual accounts filed
  3. 28-12-2024Liquidity doubles
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
27-01-1975
Year ends
28-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure